Life sciences news
-
Mithra announces shelf life extension for Myring™ to 36 months
Tuesday August 4th 2020
Read more
-
Gilead en Galapagos kondigen positieve Europese CHMP opinie aan voor Jyseleca® (Filgotinib) voor de behandeling van volwassenen met matige tot ernstige reumatoïde artritis
Friday July 24th 2020
Read more
-
Aligos Therapeutics and KU Leuven announce collaboration for the development of a therapeutic candidate targeting Coronavirus
Thursday July 2nd 2020
Read more
-
US multicenter study shows Idylla™ allows rapid and accurate mutation testing results across different laboratory settings
Friday June 26th 2020
Read more
-
eTheRNA raises EUR 34 million in Series B financing to accelerate multiple mRNA therapeutic development programs through to clinical proof of concept
Wednesday June 17th 2020
Read more
-
Johnson & Johnson announces acceleration of its COVID-19 vaccine candidate
Thursday June 11th 2020
Read more
-
New analyses of Phase 2 Equator Clinical Program support durable efficacy of Filgotinib in Psoriatic Arthritis
Monday June 8th 2020
Read more
-
Filgotinib demonstrates durable efficacy and consistent safety profile at 52 weeks in Finch 1 and 3 studies in rheumatoid arthritis
Thursday June 4th 2020
Read more
-
Your news here?
-
Celyad provides update on allogeneic CAR-T franchise
Tuesday June 2nd 2020
Read more
-
argenx announces positive topline results from Phase 3 ADAPT Trial of Efgartigimod in patients with Generalized Myasthenia Gravis
Tuesday May 26th 2020
Read more
-
Gilead and Galapagos announce positive topline results of Phase 2B/3 trial of Filgotinib
Thursday May 21st 2020
Read more
More info?
Contact us
Ellen Telleir
Communication Coordinator